Its unique format shall feature game-changing research, review articles, perspectives and commentaries, news, and Analysis Watch summaries of important journal articles. Cancer Discovery is a fresh addition to the AACR’s robust publication plan. Cancer Discovery combines the expertise and experience of founding Editors-in-Chief Lewis C. Cantley, Ph.D., and Jos – Baselga, M.D., Ph.D., along with full-time professional editors. Mark W. Landis, Ph.D., provides been appointed executive editor. Cancer Discovery will make main contributions to the developing body of knowledge and be a touchstone for the varied professional community in the malignancy field, said Cantley. Baselga added, Topics will span the spectrum of cancer science and medicine; from the laboratory to the clinic to prevention and epidemiologic studies., a head in the discovery and development of small molecule medicines to combat the most challenging infectious diseases, today announced that is has been awarded around $2.0 million in eight federal grants beneath the Qualifying Therapeutic Discovery Task program.0 billion to reimburse certain costs paid or incurred during 2009 and 2010 directly linked to the conduct of a Qualifying Therapeutic Discovery Project. The Department of Health and Human Services designated such projects predicated on the prospect of them to bring about new therapies to take care of areas of unmet medical need, the potential to create and sustain jobs in the U.S.